Spyre Therapeutics, Inc. (SYRE)
68.63
-3.27
(-4.55%)
USD |
NASDAQ |
Apr 28, 16:00
68.33
-0.30
(-0.44%)
After-Hours: 20:00
Spyre Therapeutics Research and Development Expense (TTM) : 171.65M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Tyra Biosciences, Inc. | 102.38M |
| Replimune Group, Inc. | 222.70M |
| Savara, Inc. | 81.40M |
| Regeneron Pharmaceuticals, Inc. | 5.306B |
| Agios Pharmaceuticals, Inc. | 334.36M |